+44 1803 865913
By: Kerry Ten Kate and Sarah A Laird
398 pages, Figs, tabs
Explains the International Convention on Biological Diversity (CBD) and its provisions on access and benefit sharing. A sector by sector analysis is also provided for the following industries: Pharmaceuticals; Biotechnology; Agriculture and crop protection; Horticulture; Botanical medicines and neutraceuticals; Personal care products and cosmetics.
'Written by two of the world's leading authorities on the commercial use of biodiversity, this book is an invaluable resource and guide for further research. It is as practical as it is informative and should be in the hands of everyone interested in the state and fate of the world's living resources' Professor Calestous Juma, Harvard University 'Full of examples from which we can learn... this will be an invaluable resource to policy-makers, organizations studying and creating uses for genetic resources and the companies which wish to develop them' from the Foreword by Professor Sir Ghillean Prance, ex-Director, Kew Gardens and Sir Richard Sykes, ex-Chairman, Glaxo Wellcome
There are currently no reviews for this book. Be the first to review this book!
Your orders support book donation projects
The packaging of both books was superb and they are in pristine condition. Thank you again for the service.
Search and browse over 110,000 wildlife and science products
Multi-currency. Secure worldwide shipping
Wildlife, science and conservation since 1985